Cardiol Therapeutics (CRDL) Shares Outstanding (Entity) (2020 - 2026)
Cardiol Therapeutics (CRDL) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 834.66 Mn |
| 10 | Cardiol Therapeutics | 212.73 Mn | 193.88 Mn | - | 114.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.99 Mn |
| Dec 31, 2025 | 86.99 Mn |
| Sep 30, 2025 | 84.73 Mn |
| Jun 30, 2025 | 82.65 Mn |
| Mar 31, 2025 | 82.61 Mn |
| Dec 31, 2024 | 71.57 Mn |
| Sep 30, 2024 | 69.84 Mn |
| Jun 30, 2024 | 68.75 Mn |
| Mar 31, 2024 | 67.26 Mn |
| Dec 31, 2023 | 64.46 Mn |
| Sep 30, 2023 | 64.49 Mn |
| Jun 30, 2023 | 64.11 Mn |
| Mar 31, 2023 | 64.09 Mn |
| Dec 31, 2022 | 62.51 Mn |
| Sep 30, 2022 | 62.34 Mn |
| Jun 30, 2022 | 61.93 Mn |
| Mar 31, 2022 | 61.93 Mn |
| Dec 31, 2021 | 43.22 Mn |
| Sep 30, 2021 | 43.17 Mn |
| Jun 30, 2021 | 40.06 Mn |